|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0009079,
umls-concept:C0013227,
umls-concept:C0036341,
umls-concept:C0040615,
umls-concept:C0205169,
umls-concept:C0205182,
umls-concept:C0439858,
umls-concept:C0521116,
umls-concept:C0814470,
umls-concept:C2003874,
umls-concept:C2587213
|
|
pubmed:issue |
17
|
|
pubmed:dateCreated |
2006-5-18
|
|
pubmed:abstractText |
To determine the clinical and cost-effectiveness of different classes of antipsychotic drug treatment in people with schizophrenia responding inadequately to, or having unacceptable side-effects from, their current medication.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1366-5278
|
|
pubmed:author |
pubmed-author:BarnesT R ETR,
pubmed-author:DaviesLL,
pubmed-author:DunnGG,
pubmed-author:HayhurstK PKP,
pubmed-author:JonesP BPB,
pubmed-author:KerwinRR,
pubmed-author:LewisS WSW,
pubmed-author:LloydHH,
pubmed-author:MarkwickAA,
pubmed-author:MurrayR MRM,
pubmed-author:TaylorDD
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
iii-iv, ix-xi, 1-165
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16707074-Adolescent,
pubmed-meshheading:16707074-Adult,
pubmed-meshheading:16707074-Aged,
pubmed-meshheading:16707074-Antipsychotic Agents,
pubmed-meshheading:16707074-Clozapine,
pubmed-meshheading:16707074-Female,
pubmed-meshheading:16707074-Humans,
pubmed-meshheading:16707074-International Classification of Diseases,
pubmed-meshheading:16707074-Male,
pubmed-meshheading:16707074-Middle Aged,
pubmed-meshheading:16707074-Patient Satisfaction,
pubmed-meshheading:16707074-Quality of Life,
pubmed-meshheading:16707074-Schizophrenia,
pubmed-meshheading:16707074-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
|
|
pubmed:affiliation |
Division of Psychiatry, Wythenshawe Hospital, Manchester, UK.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
